Clinical Biopharma Sienna OK'd To Sell IP In Ch. 11
A Delaware bankruptcy judge on Tuesday approved the $1.7 million sale of some intellectual property of Sienna Biopharmaceuticals Inc. in its Chapter 11 sale, as the clinical biopharma company said it...To view the full article, register now.
Already a subscriber? Click here to view full article